Medacta Group S.A.
MEDGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $591 | $511 | $437 | $363 |
| % Growth | 15.6% | 16.9% | 20.4% | – |
| Cost of Goods Sold | $191 | $163 | $132 | $102 |
| Gross Profit | $399 | $348 | $305 | $261 |
| % Margin | 67.6% | 68.1% | 69.8% | 71.9% |
| R&D Expenses | $21 | $20 | $16 | $11 |
| G&A Expenses | $21 | $66 | $61 | $50 |
| SG&A Expenses | $232 | $252 | $220 | $182 |
| Sales & Mktg Exp. | $211 | $187 | $160 | $133 |
| Other Operating Expenses | $55 | $1 | $7 | $9 |
| Operating Expenses | $309 | $273 | $244 | $203 |
| Operating Income | $91 | $74 | $61 | $59 |
| % Margin | 15.4% | 14.6% | 14.1% | 16.2% |
| Other Income/Exp. Net | -$3 | -$16 | -$7 | -$3 |
| Pre-Tax Income | $88 | $59 | $55 | $55 |
| Tax Expense | $15 | $11 | $9 | $4 |
| Net Income | $73 | $47 | $46 | $52 |
| % Margin | 12.3% | 9.3% | 10.6% | 14.2% |
| EPS | 3.66 | 2.37 | 2.32 | 2.58 |
| % Growth | 54.4% | 2.2% | -10.1% | – |
| EPS Diluted | 3.65 | 2.37 | 2.31 | 2.58 |
| Weighted Avg Shares Out | 20 | 20 | 20 | 20 |
| Weighted Avg Shares Out Dil | 20 | 20 | 20 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $8 | $7 | $4 | $3 |
| Depreciation & Amortization | $65 | $43 | $38 | $31 |
| EBITDA | $161 | $120 | $107 | $98 |
| % Margin | 27.2% | 23.4% | 24.5% | 26.9% |